Mylan Inc $48.21

up +0.46


22/8/2014 04:00 PM  |  NASDAQ : MYL  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get MYL Trend Analysis - it has outperformed the S&P 500 by 16%

Partner Headlines

  1. Benzinga's Top Downgrades

    Benzinga
  2. US Stock Futures Edge Higher Ahead Of Productivity Data

    Benzinga
  3. RBC Capital Downgrades Mylan To Sector Perform

    Benzinga
  4. Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide

    IBD
  5. Mylan shares down on Q2 miss

    IBD
  6. S&P 500 Falls To Two-Month Low, Dow Drifts Further Away From The 17,00 ...

    Benzinga
  7. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD
  8. US Stock Futures Rise; Jobless Claims Report In Focus

    Benzinga
  9. UPDATE: Mylan Posts Lower Q2 Earnings, Narrows Full-Year Outlook

    Benzinga
  10. Walgreen Seen Rejecting Tax Inversion Amid Pressure

    IBD
  11. Walgreen Names New CFO Ahead of Possible Inversion

    IBD
  12. 5 Drug Companies Profiting From Generics

    Benzinga
  13. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD
  14. How Obama Could End Walgreen's Tax-Inversion Hopes

    IBD
  15. Mylan Wins Motion For Temporary Restraining Order Against Apotex For Authorized ...

    Benzinga
  16. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness
  17. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine CR ...

    Benzinga
  18. Abbott, St. Jude Top Views, But Stocks Under Pressure

    IBD
  19. Treasury Urges Halt to Tax Inversion M&A 'Abuse'

    IBD
  20. UPDATE: Bank Of America Reiterates On Mylan Following Abbott Transaction

    Benzinga
  21. AbbVie Near $54 Bil Shire Buy

    IBD
  22. Mylan, AbbVie News Shows Tax Inversion Boom Continues

    IBD
  23. Stocks Slip From Day's Highs; Kandi Zooms On Sales Report

    IBD
  24. Mylan Buying Abbott Generics Unit, Moving Abroad

    IBD
  25. Benzinga's Volume Movers

    Benzinga
  26. Morning Market Movers

    Benzinga
  27. Benzinga's Top #PreMarket Gainers

    Benzinga
  28. Novo, Other Medicals Display Healthy Action

    IBD
  29. Generic-Drug Makers Climb Ranks; Several In Buy Range

    IBD
  30. Wells Fargo Initiates Coverage On The Pharmaceutical Space

    Benzinga
  31. Mylan

    IBD
  32. Earnings Scheduled For May 1, 2014

    Benzinga
  33. Forest Acquiring Furiex To Boost GI Franchise

    IBD
  34. Stocks Open Up, Techs Stressed; March Pending Home Sales Soar

    IBD
  35. Morning Market Losers

    Benzinga
  36. Benzinga's Weekend M&A Chatter

    Benzinga
  37. Indexes Near Session Lows As Tech Stocks Are Routed

    IBD
  38. Mylan Raises Bid for Meda to 145 Kroner/Share, Shares Gain 3%

    Benzinga
  39. Mylan Shares Spike Higher; Hearing Chatter of New Meda Bid

    Benzinga
  40. Scott Black's Top First Quarter Holdings

    GuruFocus
  41. UPDATE: Mylan Launches First Generic ORTHO EVRA Patch

    Benzinga
  42. Mylan Launches Generic Lunesta Tablets

    Benzinga
  43. Mylan Says Judge Has Enforced Settlement Deal Between Mylan, Endo Related ...

    Benzinga
  44. Nasdaq Turns Solidly Higher in Volatile Action

    FoxBusiness
  45. Benzinga's Weekend M&A Chatter

    Benzinga
  46. Meda Rejects Mylan's Takeover Proposal

    Benzinga
  47. Meda Rejects Mylan's Bid

    IBD
  48. Mylan Bid Gets Rejected, But Generic-Drugmaker Rises

    IBD
  49. Mid-Afternoon Market Update: Markets Drop, Lead Lower by NASDAQ Momentum ...

    Benzinga
  50. Growth Names Pressured; Nasdaq Gives Up 50-Day Line

    IBD
Trading Center